Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given an average rating of “Moderate Buy” by the nine brokerages that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $47.8571.

A number of research analysts have recently weighed in on ASTH shares. Barclays upgraded Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Robert W. Baird set a $45.00 price target on Astrana Health in a research note on Friday, May 8th. TD Cowen increased their price target on Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. BTIG Research lifted their price objective on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, Truist Financial lifted their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th.

Astrana Health Trading Down 1.7%

Astrana Health stock opened at $40.31 on Friday. Astrana Health has a 1 year low of $18.08 and a 1 year high of $51.60. The firm’s 50 day moving average price is $41.78 and its 200-day moving average price is $31.87. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market cap of $2.25 billion, a P/E ratio of 66.08 and a beta of 0.89.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. Astrana Health’s revenue for the quarter was up 55.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.42 earnings per share. On average, equities analysts predict that Astrana Health will post 1.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Large investors have recently bought and sold shares of the business. Bank of America Corp DE lifted its position in Astrana Health by 13.3% during the first quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock valued at $14,092,000 after purchasing an additional 67,628 shares during the last quarter. Edgestream Partners L.P. increased its holdings in shares of Astrana Health by 68.3% in the 1st quarter. Edgestream Partners L.P. now owns 27,616 shares of the company’s stock worth $677,000 after buying an additional 11,209 shares during the last quarter. California State Teachers Retirement System increased its holdings in shares of Astrana Health by 24.5% in the 1st quarter. California State Teachers Retirement System now owns 51,371 shares of the company’s stock worth $1,260,000 after buying an additional 10,102 shares during the last quarter. Quantinno Capital Management LP raised its position in shares of Astrana Health by 69.4% during the 1st quarter. Quantinno Capital Management LP now owns 64,509 shares of the company’s stock valued at $1,582,000 after buying an additional 26,418 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Astrana Health by 12.2% during the 1st quarter. Renaissance Technologies LLC now owns 104,546 shares of the company’s stock valued at $2,563,000 after buying an additional 11,400 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.